Drug Safety in Developing Countries

Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug safety practice. Further, using extensive case studies, the book addresses the challenges of drug safety in developing countries. Provides a single resource for educators, professionals, researchers, policymakers, organizations and other readers with comprehensive information and a guide on drug safety related issues Describes current achievements of drug safety practice in developing countries Addresses the challenges of drug safety in developing countries Provides recommendations, including practical ways to implement strategies and overcome challenges surrounding drug safety

Produk Detail:

  • Author : Yaser Mohammed Al-Worafi
  • Publisher : Academic Press
  • Pages : 686 pages
  • ISBN : 0128204125
  • Rating : 4/5 from 21 reviews
CLICK HERE TO GET THIS BOOKDrug Safety in Developing Countries

Drug Safety in Developing Countries

Drug Safety in Developing Countries
  • Author : Yaser Mohammed Al-Worafi
  • Publisher : Academic Press
  • Release : 03 June 2020
GET THIS BOOKDrug Safety in Developing Countries

Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug

Drug Safety in Developing Countries

Drug Safety in Developing Countries
  • Author : Yaser Mohammed Al-Worafi
  • Publisher : Academic Press
  • Release : 04 June 2020
GET THIS BOOKDrug Safety in Developing Countries

Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug

Drug Benefits and Risks

Drug Benefits and Risks
  • Author : C.J. van Boxtel,B. Santoso,I.R. Edwards
  • Publisher : IOS Press
  • Release : 06 August 2008
GET THIS BOOKDrug Benefits and Risks

This updated and revised 2nd edition of Drug Benefits and Risks is an inclusive reference exploring the scientific basis and practice of drug therapy. The key concept is to look at the balance between the benefits and risks of drugs, but in this context also highlighting the social impact which drugs have in modern societies. Taking an evidence-based approach to the problem, the practice of clinical pharmacology and pharmacotherapy in the developing as well as the developed world is examined.

Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad

Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad
  • Author : Institute of Medicine,Board on Health Sciences Policy,Board on Global Health,Committee on Strengthening Core Elements of Food and Drug Regulatory Systems in Developing Countries
  • Publisher : National Academies Press
  • Release : 03 September 2012
GET THIS BOOKEnsuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad

A very high portion of the seafood we eat comes from abroad, mainly from China and Southeast Asia, and most of the active ingredients in medicines we take originate in other countries. Many low- and middle-income countries have lower labor costs and fewer and less stringent environmental regulations than the United States, making them attractive places to produce food and chemical ingredients for export. Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad explains that the diversity and scale

Quantitative Evaluation of Safety in Drug Development

Quantitative Evaluation of Safety in Drug Development
  • Author : Qi Jiang,H. Amy Xia
  • Publisher : CRC Press
  • Release : 08 December 2014
GET THIS BOOKQuantitative Evaluation of Safety in Drug Development

State-of-the-Art Methods for Drug Safety Assessment Responding to the increased scrutiny of drug safety in recent years, Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting explains design, monitoring, analysis, and reporting issues for both clinical trials and observational studies in biopharmaceutical product development. It presents the latest statistical methods for drug safety assessment. The book’s three sections focus on study design, safety monitoring, and data evaluation/analysis. The book addresses key challenges across regulatory agencies, industry,

Countering the Problem of Falsified and Substandard Drugs

Countering the Problem of Falsified and Substandard Drugs
  • Author : Institute of Medicine,Board on Global Health,Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products
  • Publisher : National Academies Press
  • Release : 20 June 2013
GET THIS BOOKCountering the Problem of Falsified and Substandard Drugs

The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common

Illicit Medicines in the Global South

Illicit Medicines in the Global South
  • Author : Mathieu Quet
  • Publisher : Routledge
  • Release : 21 October 2021
GET THIS BOOKIllicit Medicines in the Global South

This book investigates pharmaceutical regulation and the public health issue of fake or illicit medicines in developing countries. The book analyses the evolution of pharmaceutical capitalism, showing how the entanglement of market and health interests has come to shape global regulation. Drawing on extensive fieldwork in India, Kenya and Europe, it demonstrates how large pharmaceutical companies have used the fight against fake medicines to serve their strategic interests and protect their monopolies, sometimes to the detriment of access to medicines

Healthcare Management Strategy, Communication, and Development Challenges and Solutions in Developing Countries

Healthcare Management Strategy, Communication, and Development Challenges and Solutions in Developing Countries
  • Author : Emmanuel K. Ngwainmbi
  • Publisher : Lexington Books
  • Release : 08 May 2014
GET THIS BOOKHealthcare Management Strategy, Communication, and Development Challenges and Solutions in Developing Countries

Healthcare Management Strategy, Communication, and Development Challenges and Solutions in Developing Countries describes the ways in which health services, public health administration, and healthcare policies are managed in developing countries, and how intercultural, intergroup, and mass communication practices weaken development efforts in those countries. The book is suitable for undergraduate students, libraries, and companies involved with government issues, foreign services, public health, third world development, and international business.

Children and Drug Safety

Children and Drug Safety
  • Author : Cynthia A Connolly
  • Publisher : Rutgers University Press
  • Release : 11 May 2018
GET THIS BOOKChildren and Drug Safety

Children and Drug Safety traces the development, use, and marketing of drugs for children in the twentieth century, a history that sits at the interface of the state, business, health care providers, parents, and children. This book illuminates the historical dimension of a clinical and policy issue with great contemporary significance—many of the drugs administered to children today have never been tested for safety and efficacy in the pediatric population. Each chapter of Children and Drug Safety engages with

The Importance of Pharmacovigilance

The Importance of Pharmacovigilance
  • Author : World Health Organization
  • Publisher : Unknown Publisher
  • Release : 01 January 2002
GET THIS BOOKThe Importance of Pharmacovigilance

The purpose of this document is to present the case for the importance of pharmacovigilance, to record its growth and potential as a significant discipline within medical science, and to describe its impact on patient welfare and public health.

New Insights into the Future of Pharmacoepidemiology and Drug Safety

New Insights into the Future of Pharmacoepidemiology and Drug Safety
  • Author : Maria Teresa Herdeiro,Fátima Roque,Tânia Magalhães Silva,Adolfo Figueiras
  • Publisher : BoD – Books on Demand
  • Release : 13 October 2021
GET THIS BOOKNew Insights into the Future of Pharmacoepidemiology and Drug Safety

In the last decade, pharmacoepidemiology has emerged as an important field to study the use/effects of drugs in large populations in real life, allowing for improved benefits and effectiveness of drugs as well as a decline in drug-related risks. The correct assessment, reporting, monitoring, and prevention of adverse events in drugs’ development, as well as therapy and post-market surveillance, is essential to improve clinical therapies and health outcomes. This book provides a comprehensive and unique overview of the relevance,

To Err Is Human

To Err Is Human
  • Author : Institute of Medicine,Committee on Quality of Health Care in America
  • Publisher : National Academies Press
  • Release : 01 March 2000
GET THIS BOOKTo Err Is Human

Experts estimate that as many as 98,000 people die in any given year from medical errors that occur in hospitals. That's more than die from motor vehicle accidents, breast cancer, or AIDS--three causes that receive far more public attention. Indeed, more people die annually from medication errors than from workplace injuries. Add the financial cost to the human tragedy, and medical error easily rises to the top ranks of urgent, widespread public problems. To Err Is Human breaks the silence that

Drug Benefits and Risks

Drug Benefits and Risks
  • Author : Chris J. van Boxtel,Budiono Santoso,I. Ralph Edwards
  • Publisher : John Wiley & Sons
  • Release : 28 November 2001
GET THIS BOOKDrug Benefits and Risks

This is an inclusive reference exploring the scientific basis and practice of drug therapy. The key concept is to look at the balance between the benefits and risks of drugs but in this context also the social impact which drugs have in modern societies is highlighted. Taking an evidence-based approach to the problem, the practice of clinical pharmacology and pharmacotherapy in the developing as well as the developed world is examined. For this purpose the book * Covers general clinical pharmacology,